SasX is a known virulence factor of Staphylococcus aureus involved in colonisation and immune evasion of the bacterium. The sasX gene, which is located on the φSPβ prophage, is frequently found in the sequence type (ST) 239 S. aureus lineage, which is the predominant healthcare-associated clone in Asian countries. In Japan, ST239 clones have rarely been identified, and sasX-positive strains have not been reported to date. Here, we report the first identification of 18 sasX-positive methicillin-resistant S. aureus (MRSA) strains in Japanese hospitals between 2009 and 2011. All sasX-positive isolates belonged to an ST239-staphylococcal cassette chromosome mec type III (ST239-III) lineage. However, we were unable to identify additional sasX-positive MRSA strains from 2012 to 2016, indicating that the small epidemic of sasX-positive isolates observed in this study was temporary. The sequence surrounding sasX in the strain TOHH628 lacked 51 genes that encode phage packaging and structural proteins, and no bacteriophage was induced by mitomycin C. Additionally, in the TOHH628 strain, the region (64.6 kb) containing sasX showed high identity to the φSPβ-like element (71.3 kb) of the Taiwanese MRSA strain Z172. The data strongly suggest that the present sasX-positive isolates found in Japanese hospitals were transmitted incidentally from other countries.
INTRODUCTION
Staphylococcus aureus is a major human pathogen that causes various diseases ranging from skin infections to fatal invasive infections (Francis et al. 2005) . However, S. aureus also colonises the human nasal cavity and is found in approximately 30% of healthy individuals (Wertheim et al. 2005) . Nasal colonisation is considered a crucial risk factor for serious invasive S. aureus infections (Safdar and Bradley 2008) . The presence of methicillinresistant S. aureus (MRSA), which is multidrug-resistant, is associated with restricted therapeutic options and represents a serious healthcare problem worldwide.
In Japan, the rate of MRSA isolation in healthcare settings is higher than in other countries (Nichol et al. 2011 ; (Chongtrakool et al. 2006; Ozaki et al. 2009; Yanagihara et al. 2012; Nakaminami et al. 2014) . In contrast, ST239-t030 or t037-III clones are the predominant HA-MRSA lineages in Asian countries other than Japan . In 2010, a gene with 95.1% amino acid identity to sesI of Staphylococcus epidermidis was reported in the ST239-t037-III outbreak strain TW20 in the UK (Holden et al. 2010) . This gene, which encodes an LPXTG motif surface-anchored protein, was found on the φSPβ prophage of the TW20 chromosome. Surfaceanchored proteins of S. aureus are involved in binding to host molecules. Shortly thereafter, this gene was designated sasX, and other ST239-III clones carrying the sasX gene were reported in China in 2012 (Li et al. 2012) . These strains, which were found to spread rapidly, represented the causative agents of healthcare-associated infections such as those of the bloodstream and wounds in Taiwan, Hong Kong and China (Chen et al. 2013; Chen et al. 2014; Wang et al. 2014; Zhang et al. 2014) . sasXpositive ST239-III clones exhibit multidrug resistance and are known to show high MIC (4 μg/ml) for vancomycin (Chen et al. 2013; Zhang et al. 2014) . In addition, the proportion of invasive infections caused by sasX-positive MRSA was remarkably higher than that caused by sasX-negative MRSA (Li et al. 2014) . The SasX protein is known as an accelerator of biofilm formation, cell aggregation and squamous cell adhesion (Foster et al. 2014) . From these observations, sasX is now considered to not only encode a colonisation factor but also be involved in immune evasion and virulence.
In Japan, ST239-III clones have rarely been identified, and sasX-positive strains have not been reported to date. To our knowledge, the present study is the first report of the identification of 18 sasX-positive MRSA isolates from two Japanese hospitals between 2009 and 2011. Further, we performed characterisation of these isolates and determined the region containing the sasX gene. Table 1 ). The MRSA strain MW2 was used as a control strain for the prophage induction experiment (Ma et al. 2008 ).
MATERIALS AND METHODS

Bacterial strains
Molecular typing of MRSA
PCR assays for the detection of mecA, tst (encoding toxic shock syndrome toxin-1) and lukS/F-PV (encoding PantonValentine leukocidin) were performed as described previously (Nakaminami et al. 2008) . SCCmec typing was performed according to the method reported by Kondo et al. (2007) . The detection of sasX was performed according to the method reported by Li et al. (2012) . Pulsed-field gel electrophoresis (PFGE) of SmaIdigested chromosomal DNA was performed as described previously (McDougal et al. 2003; Nakaminami et al. 2008; Nakaminami et al. 2014) . The DNA patterns obtained by PFGE were analysed with BioNumerics software ver. 7.1 (Applied Maths, SintMartens-Latem, Belgium) using Dice coefficient (Optimization, 1.0%; Band tolerance, 1.0%). The strains exhibiting 100% identical banding patterns were classified as the same pulsotypes. spa typing and multilocus sequence typing (MLST) were performed as described previously (Nakaminami et al. 2014) .
Antimicrobial susceptibility testing
MICs were determined using the agar doubling-dilution method, according to the CLSI guidelines (CLSI 2009 ). The following antimicrobial agents were used: ampicillin (Wako Pure Chemical Industries, Ltd., Osaka, Japan), oxacillin (Sigma-Aldrich, Tokyo, Japan), cefotaxime (Wako), levofloxacin (Wako), clarithromycin (Wako), gentamicin (Wako), minocycline (Sigma-Aldrich) and vancomycin (Sigma-Aldrich). The breakpoints of these antimicrobial agents were defined using the CLSI interpretation criteria (CLSI 2011).
Genome analysis
The genomic sequence of the sasX-positive MRSA strain TOHH628 was determined using the Illumina MiSeq System (Illumina, CA, USA) (Glenn 2011) . Contigs were generated with Velvet 1.1.03. Subsequent nucleotide sequencing with designed primers was used to connect contigs related to this study using a 3130xL Genetic Analyzer (Life technologies, CA, USA).
A search for open reading frames (ORFs) was performed using the GENETYX software (GENETYX CORPORATION, Tokyo, Japan). A homology search was performed using the BLAST program at the DNA Data Bank of Japan (DDBJ: http://blast.ddbj.nig.ac.jp/). The nucleotide sequence of the region containing sasX in strain TOHH628 was deposited in GenBank under the accession number LC036194.
Detection of φSPβ-like element of TOHH628
Induction of prophages from Staphylococcus aureus cells using mitomycin C was performed as described previously (Ma et al. 2008) . For the detection of the φSPβ-like element of TOHH628 by PCR, primer sets were used as shown in Table 2 . All PCRs were performed using Phusion High-Fidelity DNA Polymerase (New England Biolabs Japan Inc., Tokyo, Japan) according to the manufacturer's instructions.
RESULTS
Molecular epidemiological features of sasX-positive
MRSA isolates
We screened 7116 clinical MRSA isolates from 10 hospitals in Tokyo, Japan, from 2008 to 2016; among these, only 18 isolates (0.3%) were positive for the sasX gene. Table 1 shows the sources of the sasX-positive isolates and possession of the tst and lukS/ F-PV genes. All sasX-positive isolates were negative for these two genes. Four sasX-positive isolates were obtained from four patients (one patient in 2009 and three patients in 2010) in Hospital A. The other 14 isolates were obtained from nine patients in Hospital B (six isolates from six patients in 2009, two isolates from one patient and four isolates from one patient in 2010, as well as two isolates from one patient in 2011). Some sasX-positive isolates were repeatedly cultured from the same patients. However, we were unable to find additional sasX-positive MRSA isolates from 2012 to 2016. SCCmec typing, spa typing and MLST were performed on the sasX-positive isolates. All isolates were classified into an identical lineage, specifically ST239-t037-III. Based on PFGE analysis, all four isolates from Hospital A were classified as pulsotype C (Fig. 1) . The isolates from Hospital B were divided into two pulsotypes A and B, while the pulsotype B strain TOHH456 and the pulsotype A strains TOHH500, TOHH502 and TOHH508 were isolated from the same patient (TOHH8) ( Table 1) . Thus, the data suggest that the pulsotype B strain derived from the pulsotype A strain and reverted to pulsotype A strain in the same patient. The PFGE banding patterns for sasX-positive isolates were similar to each other. A nosocomial outbreak may have occurred in Hospital A, as evidenced by the fact that the pulsotype C strains TNH221, TNH234 and TNH242 were isolated within two months in the same clinical department. In addition, nosocomial spread may have occurred in Hospital B, as the pulsotype A strains TOHH313, TOHH331, TOHH340, TOHH350, TOHH396 and TOHH440 were isolated within four months from different clinical departments. Resistance rates to the non-β-lactams levofloxacin, gentamicin, clarithromycin and minocycline were 100%, 100%, 83.3% and 11.1%, respectively. All sasXpositive isolates had a low MIC for vancomycin; these values were less than 2 μg/ml (Table 1 ). These data showed that a small epidemic caused by sasX-positive isolates occurred in the tested two Japanese hospitals; however, this outbreak was limited and temporary.
Characterization of the sasX-containing region of the TOHH628 genome
The genomic sequence of strain TOHH628, one of the sasXpositive isolates found in this study, was determined and the sequence surrounding the sasX gene was analysed (Fig. 2) . When the region containing sasX was compared to that of other staphylococcal genomes, it was found to possess high sequence identity to the φSPβ prophage of Staphylococcus epidermidis strain RP62A (Soderquist et al. 2009 ) and MRSA strain TW20 (Holden et al. 2010) , as well as to the φSPβ-like element of the MRSA strain Z172 (Chen et al. 2013) . The sasX gene of TOHH628 was found to be located at the right end of a region that is similar to three other genomic regions; however, it was determined to TOHH9), were isolated repeatedly from the same patients (Table 1) . b LVFX, levofloxacin; CAM, clarithromycin; GM, gentamicin; MINO, minocycline. c Strains showed intermediate resistance.
Figure 2.
Comparative analysis of the region containing sasX in TOHH628 with the RP62A φSPβ prophage, TW20 φSPβ prophage and Z172 φSPβ-like element. The genomic sequence of the sasX-positive MRSA strain TOHH628 was determined using the Illumina MiSeq System (Glenn 2011) . Contigs were generated with Velvet 1.1.03. Subsequent nucleotide sequencing with designed primers was performed to connect contigs related to this study using a 3130xL Genetic Analyzer. A search for ORFs was performed using the GENETYX software. A homology search was performed using the BLAST program at the DDBJ (http://blast.ddbj.nig.ac.jp/). The nucleotide sequence of the region containing sasX in strain TOHH628 was deposited in GenBank under the accession number LC036194. The φSPβ-like element of TOHH628 was compared to φSPβ prophages of S. epidermidis RP62A and MRSA TW20 and the φSPβ-like element of MRSA Z172; the GenBank accession numbers are CP000029, FN433596 and CP006838, respectively. Homologous regions are coloured with identity (%). The triangles under the TOHH628 structure indicate primers used for the detection of the φSPβ-like element in all ST239 isolates found in this study.
be shorter (>60 kb) than that of RP62A and TW20, encoding only 100 coding DNA sequences (CDSs). Relative to φSPβ of TW20, the region in TOHH628 was found to be missing 51 CDSs that encode phage packaging and structural proteins. No bacteriophage from TOHH628 was induced by mitomycin C treatment. Therefore, the results suggest that the region containing sasX of TOHH628 cannot act as a bacteriophage.
This region in TOHH628 showed high sequence identity to the φSPβ-like element of Z172, except for the absence of the Tn4001 element, which contains the aminoglycoside resistance determinant aacA-aphD. These findings suggest that the sasXpositive isolates were transmitted to Japan incidentally from other countries, such as Taiwan, Hong Kong and China. In order to elucidate the distribution of the φSPβ-like element of TOHH628 among 17 sasX-positive isolates found in this study, PCR was performed using 16 primer sets based on the TOHH628 sequence (Table 2 and Fig. 2) . As a result, 16 PCR products with sizes identical to that of TOHH628 were detected in all isolates. Therefore, all sasX-positive isolates found in this study had a φSPβ-like element that was analogous to that of TOHH628.
DISCUSSION
In the present study, we identified the sasX-positive MRSA with extremely low rate (0.3%) for the first time in Japan. Our data indicate the occurrence of a small epidemic of sasX-positive isolates; however, this outbreak was limited, temporary and restricted to only two Japanese hospitals. Furthermore, the sasX gene of strain TOHH628 was located within a 64.6-kb region that showed high sequence identity to the φSPβ-like element of the Taiwanese MRSA strain Z172. Our findings suggest that the sasXpositive isolates were transmitted to Japanese patients incidentally from other countries; however, these isolates were unable to persist in Japanese hospitals.
All sasX-positive MRSA isolates identified in this study were classified into the same ST239-t037-III lineage and exhibited closely related PFGE patterns. The findings suggest that a small epidemic caused by sasX-positive strains may have occurred independently in Hospital A and Hospital B. All of the patients who carried the sasX-positive strain were Japanese; therefore, we speculate that the sasX-positive strains discovered in the present study were transmitted incidentally from carriers from other countries such as Taiwan, as the region containing sasX of TOHH628 is closely related to the φSPβ-like element of the Taiwanese MRSA strain Z172. However, this could not be confirmed as information regarding overseas travel records for the sasX-positive MRSA-carrying patients was unavailable. However, ST239-III-lineage MRSA is very rare in Japan and has not been detected in the present hospitals since 2012. Our data showed that the sasX-positive ST239-III clone is uncommon in Japan, resulting in its low prevalence in Japanese hospitals. This is strongly supported by the fact that there have been few reports of the isolation of ST239-III-lineage MRSA in Japan to date.
As shown in Fig. 2 , highly similar ORFs of sesI and sasX were found in the φSPβ prophages of RP62A and TW20, respectively (Holden et al. 2010; Li et al. 2012) . However, the sasX-containing φSPβ-like element of Z172 and the region containing sasX of TOHH628 have lost genes encoding phage packaging and structural proteins. The data suggest that the φSPβ-like element carrying sasX originated from coagulase-negative staphylococci, and was transferred by bacteriophages to Staphylococcus aureus. This was putatively followed by the loss of phage-related packaging and lysis genes and aminoglycoside resistance determinants, resulting in the formation of the φSPβ-like element. The IS256 transposase is considered to have played an important role in the formation of the defective phage as deletions surrounding the IS256 element have frequently been observed (Prudhomme et al. 2002) . As expected, no phage was induced by mitomycin C treatment in TOHH628, suggesting that the sasX-containing φSPβ-like element of TOHH628 cannot act as a bacteriophage.
All sasX-positive isolates found in this study possessed a φSPβ-like element that was analogous to that of TOHH628. The data strongly suggest that pulsotypes A and C sasX-positive MRSA were transmitted separately to patients in Hospitals B and A, respectively, resulting in small outbreaks. However, the sasX-positive MRSA was unable to persist in Japanese hospitals. ST5-II S. aureus, which is referred to as the New York/Japan clone, is still the predominant lineage of HA-MRSA in Japan (Otto 2012; Nakaminami et al. 2014) . Therefore, we presume that the ST5-II clones possess a greater adaptive advantage in Japanese hospitals than the ST239-III clones. Further study is necessary to confirm this hypothesis.
